Sociedad Americana de Hirudoterapia

Stroke After Transcatheter Aortic Valve Replacement: Incidence, Definitions, Etiologies and Management Options

Review published in Journal of cardiothoracic and vascular anesthesia (2017)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewEnsayos clínicosPatel PA et al. · Journal of cardiothoracic and vascular anesthesia, 2017

Abstract

Neurologic complications after transcatheter aortic valve replacement are devastating. The etiologies of stroke in this setting are best addressed in an integrated fashion during each phase of the perioperative pathway. The conduct of this triphasic approach will continue to be refined to reduce the stroke risks even further, given the major focus on aspects such as embolic protection devices and valve thrombosis. This neurologic focus in transcatheter aortic valve replacement has transformed the investigational approach to neurologic events in cardiovascular clinical trials, resulting in novel guidelines for the diagnosis and assessment of neurologic injury after cardiovascular interventions.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsCognitionHumansIncidenceStrokeTranscatheter Aortic Valve Replacement

Resumen

Neurologic complications after transcatheter aortic valve replacement are devastating.

Por qué esto importa para la hirudoterapia

This article addresses neurologic complications after transcatheter aortic valve replacement, emphasizing a triphasic perioperative approach to addressing stroke etiologies and noting the roles of embolic protection devices and valve thrombosis. It also discusses novel guidelines for the diagnosis and assessment of neurologic injury after cardiovascular interventions. There is no mention of leeches, hirudotherapy, hirudin, or leech-derived agents anywhere in the abstract. Consequently, this article has no defensible relevance to ASH's domain of hirudotherapy or the leech secretome, and is included only for completeness.

Citación

Stroke After Transcatheter Aortic Valve Replacement: Incidence, Definitions, Etiologies and Management Options

Patel PA et al. · Journal of cardiothoracic and vascular anesthesia, 2017

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.